5 Einträge gefunden

1. Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

   1. Mai, Elias K
   2. Miah, Kaya
   3. Bertsch, Uta
   4. Dürig, Jan
   5. Scheid, Christof
   6. Weisel, Katja C
   7. Kunz, Christina

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial

   1. Hungria, Vania
   2. Beksac, Meral
   3. Weisel, Katja C
   4. Nooka, Ajay K
   5. Masszi, Tamas
   6. Spicka, Ivan
   7. Munder, Markus

   2021 - Forschungsinformationssystem des UKE
3. Current Treatment Approaches to Newly Diagnosed Multiple Myeloma

   1. Ghandili, Susanne
   2. Weisel, Katja C
   3. Bokemeyer, Carsten
   4. Leypoldt, Lisa Beatrice

   2021 - Forschungsinformationssystem des UKE
4. Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation

   1. Thiele, Benjamin
   2. Binder, Mascha
   3. Schliffke, Simon
   4. Frenzel, Christian
   5. Dierlamm, Judith
   6. Wass, Maxi
   7. Weisel, Katja C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial

   1. Klein, Eva-Maria
   2. Tichy, Diana
   3. Salwender, Hans J
   4. Mai, Elias K
   5. Duerig, Jan
   6. Weisel, Katja C
   7. Benner, Axel

   2021 - Forschungsinformationssystem des UKE - frei zugänglich